All In Biotech

Drug Trial Radar · NCT06025578

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Last checked: Nov 19, 2026Latest source record: Apr 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,057 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,057

Planned (sponsor's estimate)

Start

Oct 25, 2023

Primary completion

Dec 27, 2027

Study completion Dec 27, 2027

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Sep 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Conditions

  • Progressive Pulmonary Fibrosis

Interventions

  • BMS-986278Drug

    Specified dose on specified days

  • BMS-986278 PlaceboDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants that experience spontaneous syncopal eventsTime frame: At approximately 4 weeks
  2. Absolute change from baseline in forced vital capacity (FVC) measured in mLTime frame: At Week 52

Locations

459 sites in 35 countries. Site status is shown where the registry gives one.

  • Local Institution - 0046

    Birmingham, Alabama

  • Local Institution - 0314

    Phoenix, Arizona

  • Local Institution - 0336

    La Jolla, California

  • Local Institution - 0212

    Los Angeles, California

  • Local Institution - 0019

    Los Angeles, California

  • Local Institution - 0535

    Newport Beach, California

  • Local Institution - 0366

    Orange, California

  • Local Institution - 0341

    Sacramento, California

  • Local Institution - 0015

    San Francisco, California

  • Local Institution - 0352

    Stanford, California

  • Local Institution - 0321

    Aurora, Colorado

  • Local Institution - 0376

    Denver, Colorado

  • Local Institution - 0211

    New Haven, Connecticut

  • Local Institution - 0418

    Stamford, Connecticut

  • Local Institution - 0067

    Newark, Delaware

  • Local Institution - 0354

    Washington D.C., District of Columbia

  • Local Institution - 0195

    Brandon, Florida

  • Local Institution - 0380

    Celebration, Florida

  • Local Institution - 0013

    Clearwater, Florida

  • Local Institution - 0396

    DeBary, Florida

  • Local Institution - 0036

    Gainesville, Florida

  • Local Institution - 0193

    Gainesville, Florida

  • Local Institution - 0073

    Loxahatchee Groves, Florida

  • Local Institution - 0220

    Ocala, Florida

  • Local Institution - 0452

    Pensacola, Florida

  • Local Institution - 0389

    St. Petersburg, Florida

  • Local Institution - 0316

    Tampa, Florida

  • Local Institution - 0070

    Atlanta, Georgia

  • Local Institution - 0368

    Dublin, Georgia

  • Local Institution - 0435

    Chicago, Illinois

  • Local Institution - 0023

    Chicago, Illinois

  • Local Institution - 0040

    Evanston, Illinois

  • Local Institution - 0082

    Maywood, Illinois

  • Local Institution - 0080

    Iowa City, Iowa

  • Local Institution - 0049

    Kansas City, Kansas

  • Local Institution - 0045

    Louisville, Kentucky

  • Local Institution - 0361

    Louisville, Kentucky

  • Local Institution - 0305

    Baltimore, Maryland

  • Local Institution - 0033

    Towson, Maryland

  • Local Institution - 0404

    Boston, Massachusetts

Showing 40 of 459 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.